Standard Biotools (LAB) EBT Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 423.00 |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | -4,612.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,612.00 |
| Mar 31, 2026 | -311.00 |
| Dec 31, 2025 | -54,141.00 |
| Sep 30, 2025 | -5,075.00 |
| Jun 30, 2025 | 26,297.00 |
| Mar 31, 2025 | 17,385.00 |
| Sep 30, 2024 | -4,085.00 |
| Jun 30, 2024 | -5,316.00 |
| Mar 31, 2024 | -784.00 |
| Dec 31, 2023 | 8,672.00 |
| Sep 30, 2023 | -6,692.00 |
| Jun 30, 2023 | -616.00 |
| Mar 31, 2023 | -568.00 |
| Dec 31, 2022 | 60,522.00 |
| Sep 30, 2022 | -6,447.00 |
| Jun 30, 2022 | -29,415.00 |
| Mar 31, 2022 | -20,557.00 |
| Sep 30, 2021 | -424.00 |
| Jun 30, 2021 | 244.00 |
| Mar 31, 2021 | -533.00 |